Trends in spasticity-reducing surgery and botulinum toxin treatment for post-stroke spasticity: a register study on 6,258 patients in Sweden, 2010–2021
Journal of Rehabilitation Medicine · 2025
DOI: 10.2340/jrm.v57.42684 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Rehabilitation Medicine, 2025. Verfasst von Marcus Sagerfors und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics and Hand Surgery, Faculty of Medicine and Health, Örebro University, Örebro, Sweden. marcus.sagerfors@regionorebrolan.se. Hauptthemen laut MEDLINE: Muscle Spasticity, Stroke, Botulinum Toxins, Type A, Neuromuscular Agents. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Schlaganfall
Abstract (Originalsprache)
Spasticity is characterized by increased muscle tone, which can result in pain, contractures, impaired hygiene, and deformities. Stroke is a leading cause of paresis, and nearly 40% of stroke patients will develop spasticity.
Objective
To assess trends in upper and lower extremity spasticity-reducing surgery and botulinum toxin A (BoNT-A) treatment.
Design
A national cohort register study.
Methods
Upper and lower extremity spasticity-reducing surgery and BoNT-A treatment in Swedish stroke patients over a 12-year period was assessed using the National Patient Register.
Results
A total of 6,258 patients were treated during this period; their mean age was 58, and the majority were male. In both upper and lower extremities, tenotomy was the most common surgical procedure, followed by tendon lengthening. The need for BoNT-A injections was significantly reduced after surgery compared with before surgery. The total number of BoNT-A treatments increased during the study period, and ultrasound guidance of injections became more common.
Conclusion
The frequency of BoNT-A treatments was significantly reduced in patients who underwent surgery. Even though no causative association can be established due to the nature of these registry data, this may indicate that surgery reduces the need for further BoNT-A treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics and Hand Surgery, Faculty of Medicine and Health, Örebro University, Örebro, Sweden. marcus.sagerfors@regionorebrolan.se.
- Department of Diagnostic and Intervention, Hand and Plastic Surgery, Umeå University, Sweden.
- Hand Center Malmö, Atleva Specialist Care, Sweden.
- Sahlgrenska Osteoporosis Centre, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden.
- University of Gothenburg, Sahlgrenska Academy, Institution of Clinical Sciences, Department of Hand Surgery and Department of Surgery and Orthopaedics, Alingsås lasarett, Alingsås, Sweden.
ORCID-Profile: Marcus Sagerfors, Helena Johansson, Joakim Strömberg
Zitieren
APA
Sagerfors, M., Blaszczyk, I., Chemnitz, A., Johansson, H., & Strömberg, J. (2025). Trends in spasticity-reducing surgery and botulinum toxin treatment for post-stroke spasticity: a register study on 6,258 patients in Sweden, 2010–2021. Journal of Rehabilitation Medicine. https://doi.org/10.2340/jrm.v57.42684
Vancouver
Sagerfors M, Blaszczyk I, Chemnitz A, Johansson H, Strömberg J. Trends in spasticity-reducing surgery and botulinum toxin treatment for post-stroke spasticity: a register study on 6,258 patients in Sweden, 2010–2021. Journal of Rehabilitation Medicine. 2025. doi:10.2340/jrm.v57.42684
BibTeX
@article{Sagerfors2025,
author = {Sagerfors, Marcus and Blaszczyk, Izabela and Chemnitz, Anette and Johansson, Helena and Strömberg, Joakim},
title = {Trends in spasticity-reducing surgery and botulinum toxin treatment for post-stroke spasticity: a register study on 6,258 patients in Sweden, 2010–2021},
journal = {Journal of Rehabilitation Medicine},
year = {2025},
doi = {10.2340/jrm.v57.42684}
}
EUVIMED